Melanoma is, sadly, a problem that is “growing” on more and more Australians. ACMAV held a refresher seminar on this topic and also covered recent advances in melanoma management.
As a special treat, member Jason Chuen brought along some 3D-printed models!
Note: This seminar was supported by MSD Australia, distributors of pembrolizumab (Keytruda®), a new targeted anti-PD1 immunotherapy for metastatic melanoma which has been temporarily approved for use under the PBS under the Managed Entry Scheme (MES).
On Saturday 20 Feb 2016, the year of the monkey started with a full belly. The ACMAV membership gathered at China Bar Signature, Burwood, for a grand feast. We welcomed new members and it was a rare opportunity for ACMAV members and their families to get together for a purely social occasion. This year, instead of the classic yum cha, we enjoyed a smorgasbord of delectables on offer in the buffet. Thank you to Central Equity for donating the door prize, won by Dr John Chew.